Trump announces landmark trade deal with EU
In a recent transaction disclosed by Agilent Technologies, Inc. (NYSE:A), Director Sue H. Rataj sold 6,971 shares of the company’s common stock. The shares were sold at an average price of $126.382, amounting to a total transaction value of approximately $881,008. The transaction comes as Agilent trades near its 52-week low of $121.45, with the stock down about 15% over the past year. According to InvestingPro analysis, the company currently trades close to its Fair Value. Following this sale, Rataj retains ownership of 19,640 shares in the company. The transaction took place on March 6, 2025, as per the SEC Form 4 filing. While this insider sale has attracted attention, InvestingPro data shows the company maintains strong fundamentals with a "GOOD" Financial Health score and has been actively buying back shares. Get access to 12+ additional exclusive ProTips and comprehensive analysis in the Pro Research Report.
In other recent news, Agilent Technologies reported a strong start to 2025, surpassing Wall Street’s expectations for its first-quarter earnings. The company posted an earnings per share (EPS) of $1.31, exceeding the forecast of $1.27, and revenue reached $1.68 billion, slightly above the anticipated $1.67 billion. Despite this positive performance, the company anticipates a softer outlook for the second quarter, although its full-year guidance remains unchanged with an expectation of around 3% organic growth. Agilent’s recent product launches, particularly in liquid chromatography, are gaining traction, contributing to its steady performance. Stifel analysts have maintained a Buy rating for Agilent, with a price target of $151, reflecting confidence in the company’s market position. The company is also seeing strong growth in PFAS testing and food markets, although the pharma market remained flat globally. Agilent’s strategic initiatives aim at margin expansion, with ongoing efforts to navigate challenges such as potential impacts from tariffs and changes in NIH funding.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.